Feedback control of the arachidonate cascade in osteoblastic cells by 15-deoxy-Δ12,14-prostaglandin J2

被引:2
|
作者
Ishino, Hidetaka [1 ]
Kawahito, Yutaka [1 ]
Tsubouchi, Yasunori [1 ]
Kohno, Masataka [1 ]
Wada, Makoto [1 ]
Yamamoto, Aihiro [1 ]
Hamaguchi, Masahide [1 ]
Kadoya, Masatoshi [1 ]
Tokunaga, Daisaku [1 ]
Hojo, Tatsuya [1 ]
Matsuyama, Masahide [2 ]
Yoshimura, Rikio [2 ]
Yoshikawa, Toshikazu [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan
[2] Osaka City Univ Hosp, Dept Urol, Osaka 5458585, Japan
关键词
15d-PGJ(2); PPAR-gamma; osteoblast; PGE(2); COX-2;
D O I
10.3164/jcbn.2008011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and an anti-diabetic thiazolidinedione, troglitazone (TRO) are peroxisome proliferator-activated receptor (PPAR)-gamma ligands, which regulate immuno-inflammatory reactions as well as adipocyte differentiation. We previously reported that 15d-PGJ(2) can suppress interleukin (IL)-1 beta-induced prostaglandin E-2 (PGE(2)) synthesis in synoviocytes of rheumatoid arthritis (RA). IL-1 also stimulates PGE2 synthesis in osteoblasts by regulation of cyclooxygenase (COX)-2 and regulates osteoclastic bone resorption in various diseases such as RA and osteoporosis. In this study, we investigated the feedback mechanism of the arachidonate cascade in mouse osteoblastic cells, MC3T3-E1 cells, which differentiate into mature osteoblasts. Treatment with 15d-PGJ(2) led to a significant increase in IL-1 alpha-induced COX-2 expression and PGE2 production in a dose dependent manner. The effect of 15d-PGJ(2) was stronger than that of TRO. However, it did not affect the expression of COX-1. In addition, cell viability of MC3T3-E1 cells was not changed in the condition we established. This means that 15d-PGJ(2) exerts a positive feedback regulation of the arachidonate cascade of PGE(2) in osteoblastic cells. These results may provide important information about the pathogenesis and treatment of bone resorption in a variety of diseases such as RA and osteoporosis.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 50 条
  • [41] 15-Deoxy-Δ12,14-prostaglandin J2 and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues
    Lappas, M.
    Permezel, M.
    Rice, G. E.
    PLACENTA, 2006, 27 (11-12) : 1060 - 1072
  • [42] Cytotoxicity of 15-Deoxy-Δ12,14-prostaglandin J2 through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
    Fujita, Megumi
    Tohji, Chiaki
    Honda, Yoko
    Yamamoto, Yasuhiro
    Nakamura, Tsutomu
    Yagami, Tatsurou
    Yamamori, Motohiro
    Okamura, Noboru
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (07): : 555 - 566
  • [43] Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2
    Pei-Pei Guan
    Yun-Yue Liang
    Long-Long Cao
    Xin Yu
    Pu Wang
    Neurotherapeutics, 2019, 16 : 1255 - 1268
  • [44] 15-Deoxy-Δ12,14-prostaglandin J2 down-regulates CXCR4 on carcinoma cells through PPARγ- and NFκB-mediated pathways
    Richard, Cynthia Lee
    Lowthers, Erica Lauren
    Blay, Jonathan
    EXPERIMENTAL CELL RESEARCH, 2007, 313 (16) : 3446 - 3458
  • [45] Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2
    Marcone, Simone
    Fitzgerald, Desmond J.
    PROTEOMICS, 2013, 13 (14) : 2135 - 2139
  • [46] 15-deoxy-Δ12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells
    Józkowicz, A
    Nigisch, A
    Winter, B
    Weigel, G
    Huk, I
    Dulak, J
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2004, 74 (1-4) : 11 - 28
  • [47] Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15-deoxy-Δ12,14 prostaglandin J2
    Nicolas Penas, Federico
    Carolina Cevey, Agata
    Siffo, Sofia
    Ariel Mirkin, Gerardo
    Beatriz Goren, Nora
    EXPERIMENTAL PARASITOLOGY, 2016, 170 : 100 - 108
  • [48] 15-Deoxy-Δ12,14 Prostaglandin J2 Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
    Seno, Takahiro
    Hamaguchi, Masahide
    Ashihara, Eishi
    Kohno, Masataka
    Ishino, Hidetaka
    Yamamoto, Aihiro
    Kadoya, Masatoshi
    Nakamura, Kaoru
    Murakami, Ken
    Matoba, Satoaki
    Maekawa, Taira
    Kawahito, Yutaka
    PLOS ONE, 2011, 6 (10):
  • [49] Elevated concentrations of 15-deoxy-Δ12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ-inducing drugs
    Gressner, Olav A.
    Gao, Chunfang
    Rehbein, Katharina
    Lahme, Birgit
    Siluschek, Monika
    Berg, Thomas
    Mueller, Tobias
    Gressner, Axel M.
    LIVER INTERNATIONAL, 2009, 29 (05) : 730 - 735
  • [50] Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes
    Hovsepian, Eugenia
    Mirkin, Gerardo A.
    Penas, Federico
    Manzano, Anna
    Bartrons, Ramon
    Goren, Nora B.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2011, 41 (05) : 553 - 562